Clinical Trial

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 12, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to collect data on efficacy and safety of microwave ablation (MWA) used to treat subjects with primary and secondary liver malignancies and renal malignancies. The main question it aims to evaluate the short, medium and long-term clinical course of patients treated with MWA. Participants will not alter their normal clinical and therapeutic practice, due to the observational nature of the study, and all data regarding microwave treatments will be collected (including demographic data). follow their normal clinical and therapeutic path
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-06-07; most recent amendment 2024-04-11.
Trial Details
NCT Number NCT03981497
Lead Sponsor Francesco De Cobelli
Conditions Liver Cancer, Liver Metastasis Colon Cancer, Kidney Cancer, Renal Cell Carcinoma
Enrollment 500 participants
Start Date 2018-02-28
Primary Completion 2025-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-12